REGISTERED
on 10 Nov 2020
Last Applicant/ Owned by
60 Leveroni Court
Novato
CA
94949
Serial Number
88707194 filed on 26th Nov 2019
Registration Number
6196836 registered on 10th Nov 2020
Correspondent Address
Brian Focarino
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
DOJOLVI
Pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)
First Use Date in General
21st Jul 2020
First Use Date in Commerce
21st Jul 2020
Mark Details
Serial Number
No 88707194
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 315613-20000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.06 -
Semi-circles
26.19.01 -
Spheres
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Aug 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 02th Aug 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 02th Aug 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 02th Aug 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 02th Aug 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 10th Nov 2020 | REGISTERED-PRINCIPAL REGISTER |
| 03rd Oct 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 02th Oct 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 11th Sep 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 10th Sep 2020 | STATEMENT OF USE PROCESSING COMPLETE |